168 related articles for article (PubMed ID: 33062295)
1. Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients.
Van Hulle H; Vakaet V; Post G; Van Greveling A; Monten C; Hendrix A; Van de Vijver K; Van Dorpe J; De Visschere P; Braems G; Vandecasteele K; Denys H; De Neve W; Veldeman L
Pilot Feasibility Stud; 2020; 6():154. PubMed ID: 33062295
[TBL] [Abstract][Full Text] [Related]
2. Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial.
Vakaet V; Van Hulle H; Van de Vijver K; Hilderson I; Naert E; De Neve W; Vandorpe J; Hendrix A; Göker M; Depypere H; Vergauwen G; Van den Broecke R; De Visschere P; Braems G; Vandecasteele K; Denys H; Veldeman L
Breast; 2022 Apr; 62():10-15. PubMed ID: 35091184
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
[TBL] [Abstract][Full Text] [Related]
4. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
6. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
7. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
Chatterjee S; Chakraborty S;
Trials; 2020 Sep; 21(1):819. PubMed ID: 32998747
[TBL] [Abstract][Full Text] [Related]
9. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
[TBL] [Abstract][Full Text] [Related]
10. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.
Weinstein GD; Rich TA; Shumate CR; Skibber JM; Cleary KR; Ajani JA; Ota DM
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):197-204. PubMed ID: 7721616
[TBL] [Abstract][Full Text] [Related]
11. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.
Pinnarò P; Soriani A; Landoni V; Giordano C; Papale M; Marsella A; Marucci L; Arcangeli G; Strigari L
J Exp Clin Cancer Res; 2010 Jan; 29(1):9. PubMed ID: 20100335
[TBL] [Abstract][Full Text] [Related]
12. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
13. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA;
Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
16. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M
Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969
[TBL] [Abstract][Full Text] [Related]
17. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.
Fonteyne V; Dirix P; Junius S; Rammant E; Ost P; De Meerleer G; Swimberghe M; Decaestecker K
BMC Cancer; 2017 May; 17(1):308. PubMed ID: 28464906
[TBL] [Abstract][Full Text] [Related]
19. Highly Accelerated Irradiation in 5 Fractions (HAI-5): Feasibility in Elderly Women With Early or Locally Advanced Breast Cancer.
Monten C; Lievens Y; Olteanu LAM; Paelinck L; Speleers B; Deseyne P; Van Den Broecke R; De Neve W; Veldeman L
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):922-930. PubMed ID: 28366576
[TBL] [Abstract][Full Text] [Related]
20. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
